Abstract
Acute Myeloid Leukemia (AML) is a hematopoietic neoplasm of the myeloid lineage, characterized by the proliferation of myeloid blasts in the bone marrow, in the peripheral blood and/or in other tissues. The treatment of patients with AML depends on the definition of the disease subtype and on the prognostic risk stratification. The analysis of genetic and molecular abnormalities present a…